SEC Company Response from OptimizeRx Corp (OPRX) (CIK 0001448431) (OPRX) — Dec 10, 2018

OptimizeRx Corp (OPRX) (CIK 0001448431)
Date: Dec. 10, 2018 · CIK: 0001448431 · Accession: 0001213900-18-017174

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-228357

Date

December 10, 2018

Author

Not clearly detected

Form

CORRESP

Company

OptimizeRx Corp (OPRX) (CIK 0001448431)

Letter

Division of Corporation Finance Re: OptimizeRx Corporation Registration Statement on Form S-3 File No. 333-228357

Dear Mr. Austin:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, OptimizeRx Corporation (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 to 4:30 PM Eastern Standard Time on December 11, 2018, or as soon thereafter as is practicable.

Thank you for your assistance. Please call with any questions.

OptimizeRx Corp

By: /s/ Doug Baker

Doug Baker

Chief Financial Officer

400 Water Street Suite 200

Rochester, MI, 48307- Phone: 248 651-6568

Show Raw Text

CORRESP
1
filename1.htm

OptimizeRx
CorpORATION

December 10, 2018

THE UNITED STATES SECURITIES

AND EXCHANGE COMMISSION

Attn: Mitchell Austin

Division of Corporation Finance

Mail Stop 7010

100 F. Street NE

Washington, D.C. 20549-7010

    Re:

    OptimizeRx Corporation

Registration
Statement on Form S-3

File
No. 333-228357

Dear Mr. Austin:

Pursuant to Rule 461 under the Securities
Act of 1933, as amended, OptimizeRx Corporation (the “Company”) hereby requests acceleration of the effective date
of its Registration Statement on Form S-3 to 4:30 PM Eastern Standard Time on December 11, 2018, or as soon thereafter as is practicable.

Thank you for your assistance. Please call
with any questions.

    OptimizeRx Corp

    By:
    /s/ Doug Baker

    Doug Baker

    Chief Financial Officer

400 Water Street Suite 200

Rochester, MI, 48307- Phone: 248 651-6568

SecProbe.io